{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2014-N-0002\" sorted by posted_date descending", "rows": [["FDA-2014-N-0002-0085", "FDA", "FDA-2014-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "Final Rule", "2016-07-26T04:00:00Z", 2016, 7, "2016-07-26T04:00:00Z", null, "2016-07-26T14:45:37Z", "2016-17501", 0, 0, "09000064821222dc"], ["FDA-2014-N-0002-0084", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-512 TRIAMULOX\ntiamulin hydrogen fumarate, 12.3% Liquid Concentrate Swine re New Animal Drugs; Approval of New Animal Drug Applications; Change of\nSponsor", "Supporting & Related Material", "Background Material", "2015-03-17T04:00:00Z", 2015, 3, null, null, "2015-03-17T13:58:43Z", null, 0, 0, "0900006481a45f51"], ["FDA-2014-N-0002-0081", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-276 ZILMAX plus RUMENSIN plus TYLAN (zilpaterol hydrochloride 4.8%; monensin, USP; and tylosin phosphate) Type A Medicated Articles For Use in the Manufacture of Type B and C Medicated Feeds Cattle Fed in Confinement for Slaughter re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:57Z", null, 0, 0, "0900006481a45f5c"], ["FDA-2014-N-0002-0071", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-522 Carprofen Sterile Injectable Solution carprofen Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T12:57:49Z", null, 0, 0, "0900006481971dae"], ["FDA-2014-N-0002-0075", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-575\nCarprofen Chewable Tablets Carprofen Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:20Z", null, 0, 0, "0900006481a45f53"], ["FDA-2014-N-0002-0074", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-573\nDexmedetomidine HCl dexmedetomidine hydrochloride Sterile Injectable Solution Dogs and cats re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:12Z", null, 0, 0, "0900006481a45f52"], ["FDA-2014-N-0002-0077", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-034 GAINPRO\nbambermycins Type A Medicated Article to be used in the manufacture of Type C Medicated Feeds Pasture cattle (slaughter, stocker, and feeder cattle, and dairy and beef replacement heifers) re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:33Z", null, 0, 0, "0900006481a45f55"], ["FDA-2014-N-0002-0078", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-068 BAYTRIL 100 Injectable Solution Enrofloxacin Swine re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:39Z", null, 0, 0, "0900006481a45f59"], ["FDA-2014-N-0002-0079", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-232\nSIMPLICEF Cefpodoxime proxetil Chewable tablets Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:45Z", null, 0, 0, "0900006481a45f5a"], ["FDA-2014-N-0002-0082", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-349 DRAXXIN 25 Injectable Solution Tulathromycin Injection Cattle (suckling calves, dairy calves, and veal calves) re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:38:04Z", null, 0, 0, "0900006481a45f5d"], ["FDA-2014-N-0002-0070", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-244 DRAXXIN Tulathromycin Injectable Solution Cattle suckling calves dairy calves and veal calves re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T12:57:42Z", null, 0, 0, "0900006481971d5e"], ["FDA-2014-N-0002-0072", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-581 FLUNAZINE flunixin meglumine Paste Horses re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T12:57:58Z", null, 0, 0, "0900006481971db0"], ["FDA-2014-N-0002-0076", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-437\nOSURNIA florfenicol, terbinafine, betamethasone acetate Otic gel\nDogs re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:27Z", null, 0, 0, "0900006481a45f54"], ["FDA-2014-N-0002-0080", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-258 ZILMAX\nZilpaterol Hydrochloride 4.8% Type A medicated article to be used in the manufacture of Type B and C medicated feeds Cattle fed in confinement for slaughter re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:51Z", null, 0, 0, "0900006481a45f5b"], ["FDA-2014-N-0002-0073", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-510\nDERACIN (chlortetracycline) Type A Medicated Article Cattle, Swine, Sheep, Turkeys, Chickens, Ducks, and Psittacine Birds re New Animal Drugs; Approval of New Animal Drug Applications; Change of\nSponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:37:03Z", null, 0, 0, "0900006481a45f50"], ["FDA-2014-N-0002-0068", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary   ORIGINAL NEW ANIMAL DRUG  APPLICATION NADA 141-430 STAFAC and COBAN Virginiamycin and Monensin Type A Medicated Articles to be Used in the Manufacture of Type C Medicated Feeds Broiler Chickens re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T12:57:31Z", null, 0, 0, "09000064819718df"], ["FDA-2014-N-0002-0083", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 034-267 GENTOCIN DURAFILM (Gentamicin Sulfate and Betamethasone) Sterile Ophthalmic Solution re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T14:38:09Z", null, 0, 0, "0900006481a45f5e"], ["FDA-2014-N-0002-0069", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-540 Meloxicam Solution for Injection meloxicam Dogs and Cats re New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications", "Supporting & Related Material", "Freedom of Information Summary", "2015-03-16T04:00:00Z", 2015, 3, null, null, "2015-03-16T12:57:36Z", null, 0, 0, "0900006481971d58"], ["FDA-2014-N-0002-0067", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Change of\nSponsor", "Rule", "Final Rule", "2015-03-13T04:00:00Z", 2015, 3, "2015-03-13T04:00:00Z", null, "2015-03-13T17:08:47Z", "2015-05644", 0, 0, "0900006481a42753"], ["FDA-2014-N-0002-0065", "FDA", "FDA-2014-N-0002", "Oral Dosage Form New Animal Drugs; Withdrawal of Approval of New \nAnimal Drug Application; Oxytetracycline", "Rule", "Withdrawal", "2014-12-15T05:00:00Z", 2014, 12, "2014-12-15T05:00:00Z", null, "2015-03-23T19:19:16Z", "2014-29248", 0, 0, "0900006481976880"], ["FDA-2014-N-0002-0066", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Withdrawal of Approval of New Animal Drug Applications", "Rule", "Approval", "2014-12-15T05:00:00Z", 2014, 12, "2014-12-15T05:00:00Z", null, "2014-12-16T17:01:04Z", "2014-29249", 0, 0, "09000064819768af"], ["FDA-2014-N-0002-0059", "FDA", "FDA-2014-N-0002", "Environmental Assessment for Synovex\u00ae Choice Implants for Feedlot Beef Steers and Heifers re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor", "Supporting & Related Material", "Background Material", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:14:45Z", null, 0, 0, "0900006481901c30"], ["FDA-2014-N-0002-0064", "FDA", "FDA-2014-N-0002", "Finding of No Significant Impact (FONSI) in support of a supplemental New Animal Drug Application for SYNOVEX CHOICE (estradiol benzoate and trenbolone acetate implant) re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor", "Supporting & Related Material", "Background Material", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:15:36Z", null, 0, 0, "0900006481901c35"], ["FDA-2014-N-0002-0057", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon;\nNitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and\nSulfadiazine; Tylosin; Change of Sponsor", "Rule", "Final Rule", "2014-10-28T04:00:00Z", 2014, 10, "2014-10-28T04:00:00Z", null, "2014-10-28T15:22:07Z", "2014-25588", 0, 0, "09000064819017a0"], ["FDA-2014-N-0002-0060", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-043 SYNOVEX CHOICE\nTrenbolone and estradiol implant Subcutaneous implant Heifers fed in confinement for slaughter re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:14:56Z", null, 0, 0, "0900006481901c31"], ["FDA-2014-N-0002-0063", "FDA", "FDA-2014-N-0002", "Finding of No Significant Impact (FONSI) in support of a New Animal Drug Application for SYNOVEX ONE FEEDLOT (estradiol benzoate and trenbolone acetate extended release implant) for increased rate of weight gain and improved feed efficiency in steers and heifers fed in confinement for slaughter for a period of up to 200 days AND SYNOVEX ONE GRASS re New Animal Drugs; Alfaxalone; Dinoprost;", "Supporting & Related Material", "Background Material", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:15:28Z", null, 0, 0, "0900006481901c34"], ["FDA-2014-N-0002-0058", "FDA", "FDA-2014-N-0002", "Environmental Assessment for Synovex\u00ae ONE (Estradiol Benzoate\nand Trenbolone Acetate Extended Release Implant) Feedlot and\nGrass for Beef Steers and Heifers re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor", "Supporting & Related Material", "Background Material", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:14:38Z", null, 0, 0, "0900006481901c2f"], ["FDA-2014-N-0002-0061", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary - SYNOVEX ONE FEEDLOT (trenbolone and estradiol extended release implant). SYNOVEX ONE GRASS (trenbolone and estradiol extended release implant)  re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:15:03Z", null, 0, 0, "0900006481901c32"], ["FDA-2014-N-0002-0062", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary  NADA 140-833 IVOMEC Plus Injection for Cattle ivermectin and clorsulon injection re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor", "Supporting & Related Material", "Freedom of Information Summary", "2014-10-28T04:00:00Z", 2014, 10, null, null, "2014-10-28T17:15:11Z", null, 0, 0, "0900006481901c33"], ["FDA-2014-N-0002-0052", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-431 FOLLTROPIN Porcine pituitary-derived follicle stimulating hormone for injection Solution for Injection Cattle/beef and dairy heifers and cows", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:32Z", null, 0, 0, "0900006481872ab3"], ["FDA-2014-N-0002-0049", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-567 OPTAFLEXX 45 plus RUMENSIN plus TYLOVET 100 plus MGA ractopamine hydrochloride plus monensin USP plus tylosin phosphate plus melengestrol acetate Type A Medicated Articles for Use in the Manufacture of Type C Medicated Feeds Cattle (heifers) fed in confinement for slaughter", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:16Z", null, 0, 0, "0900006481872ab0"], ["FDA-2014-N-0002-0053", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-434 SIMBADOL Buprenorphine injection Injectable Cats", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:37Z", null, 0, 0, "0900006481872ad9"], ["FDA-2014-N-0002-0045", "FDA", "FDA-2014-N-0002", "Environmental Assessment for the Use of Tylosin Tartrate for Control\nof Necrotic Enteritis in Broiler Chickens", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:36:51Z", null, 0, 0, "0900006481872aac"], ["FDA-2014-N-0002-0046", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary  ANADA 200-520 CARPRIEVE Injection\ncarprofen Injectable Solution Dogs", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:36:57Z", null, 0, 0, "0900006481872aad"], ["FDA-2014-N-0002-0054", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 013-076 TYLAN Soluble Tylosin Tartrate Water Soluble Powder Broiler Chickens", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:46Z", null, 0, 0, "0900006481872ada"], ["FDA-2014-N-0002-0051", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-570 TYLOVET 100 plus BIO-COX tylosin phosphate plus salinomycin sodium Type A Medicated Articles For Use in the Manufacture of Type C Medicated Feeds Broiler Chickens", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:27Z", null, 0, 0, "0900006481872ab2"], ["FDA-2014-N-0002-0055", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-207 ADVOCIN Sterile Injectable Solution Danofloxacin Injection Beef Cattle", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:52Z", null, 0, 0, "0900006481872adb"], ["FDA-2014-N-0002-0048", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-566 OPTAFLEXX 45 plus RUMENSIN plus TYLOVET 100 ractopamine hydrochloride plus monensin USP plus tylosin phosphate Type A Medicated Articles for Use in the Manufacture of Type B and Type C Medicated Feeds Cattle fed in confinement for slaughter", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:09Z", null, 0, 0, "0900006481872aaf"], ["FDA-2014-N-0002-0050", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-569 TYLAN plus SACOX tylosin phosphate plus salinomycin sodium Type A Medicated Articles For Use in the Manufacture of Type C Medicated Feeds Broiler Chickens", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:21Z", null, 0, 0, "0900006481872ab1"], ["FDA-2014-N-0002-0056", "FDA", "FDA-2014-N-0002", "Finding of No Significant Impact (FONSI) for TYLAN Soluble\n(Tylosin tartrate) in Broiler Chickens", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:58Z", null, 0, 0, "0900006481872adc"], ["FDA-2014-N-0002-0047", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-559 ACTOGAIN 45 plus RUMENSIN ractopamine hydrochloride plus monensin USP Type A Medicated Articles for Use in the Manufacture of Type B and Type C Medicated Feeds Cattle Fed in Confinement for Slaughter during the last 28 to 42 days on feed", "Supporting & Related Material", "Background Material", "2014-09-15T04:00:00Z", 2014, 9, null, null, "2014-09-15T20:37:03Z", null, 0, 0, "0900006481872aae"], ["FDA-2014-N-0002-0044", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Buprenorphine; Carprofen; Danofloxacin; Follicle\nStimulating Hormone; Ractopamine; Salinomycin; Tylosin", "Rule", "Final Rule", "2014-09-08T04:00:00Z", 2014, 9, "2014-09-08T04:00:00Z", null, "2014-09-08T16:53:36Z", "2014-20325", 0, 0, "09000064818632fd"], ["FDA-2014-N-0002-0041", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary LUTALYSE (dinoprost injection) Injection re New Animal Drugs; Bacitracin Methylene Disalicylate; Dinoprost Solution; Gonadorelin Hydrochloride; Progesterone Intravaginal Inserts; Salinomycin; Ractopamine; Tylosin", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-31T04:00:00Z", 2014, 7, null, null, "2014-07-31T14:49:27Z", null, 0, 0, "09000064817f1443"], ["FDA-2014-N-0002-0040", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Bacitracin Methylene Disalicylate; Dinoprost\nSolution; Gonadorelin Hydrochloride; Progesterone Intravaginal Inserts;\nSalinomycin; Ractopamine; Tylosin", "Rule", "Final Rule", "2014-07-31T04:00:00Z", 2014, 7, "2014-07-31T04:00:00Z", null, "2014-07-31T14:23:56Z", "2014-17912", 0, 0, "09000064817f160d"], ["FDA-2014-N-0002-0042", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ACTOGAIN (ractopamine\nHCl), RUMENSIN (monensin), TYLAN (tylosin phosphate), and MGA\n(melengestrol acetate) Type B and C medicated feeds re New Animal Drugs; Bacitracin Methylene Disalicylate; Dinoprost Solution; Gonadorelin Hydrochloride; Progesterone Intravaginal Inserts;\nSalinomycin; Ractopamine; Tylosin", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-31T04:00:00Z", 2014, 7, null, null, "2014-07-31T14:49:18Z", null, 0, 0, "09000064817f1442"], ["FDA-2014-N-0002-0043", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ACTOGAIN (ractopamine\nHCl), RUMENSIN (monensin), MGA (melengestrol acetate), and\nType B and C medicated feeds re New Animal Drugs; Bacitracin Methylene Disalicylate; Dinoprost Solution; Gonadorelin Hydrochloride; Progesterone Intravaginal Inserts; Salinomycin; Ractopamine; Tylosin", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-31T04:00:00Z", 2014, 7, null, null, "2014-07-31T14:49:10Z", null, 0, 0, "09000064817ef347"], ["FDA-2014-N-0002-0036", "FDA", "FDA-2014-N-0002", "Freedom of Information ANADA 200-558 ENGAIN 9 and 45 (ractopamine HCl) plus TYLAN 100 (tylosin phosphate) Type B and C medicated feeds  re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:25:54Z", null, 0, 0, "090000648178df8d"], ["FDA-2014-N-0002-0037", "FDA", "FDA-2014-N-0002", "Freedom of Information ANADA 200-561  ACTOGAIN 45 (ractopamine HCl), RUMENSIN (monensin), and TYLAN 100 (tylosin phosphate) Type B and C medicated feeds  re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:30:03Z", null, 0, 0, "090000648178df8e"], ["FDA-2014-N-0002-0038", "FDA", "FDA-2014-N-0002", "Environmental Assessment of the Effects of Chloramine-T Use\nin and Discharge by Freshwater Aquaculture re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T18:18:57Z", null, 0, 0, "0900006481763159"], ["FDA-2014-N-0002-0030", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-426  BRAVECTO Fluralaner Chewable Tablets Dogs re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:05:24Z", null, 0, 0, "09000064817631cc"], ["FDA-2014-N-0002-0039", "FDA", "FDA-2014-N-0002", "FINDING OF NO SIGNIFICANT IMPACT for HALAMID AQUA (Chloramine-T Powder for Immersion) re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T18:19:37Z", null, 0, 0, "0900006481763158"], ["FDA-2014-N-0002-0034", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-513 ENROFLOX Injection for Dogs 2.27% enrofloxacin Injectable Solution Dogs re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:11:48Z", null, 0, 0, "090000648178df8b"], ["FDA-2014-N-0002-0031", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-427 OSPHOS Clodronate injection Horse re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:05:32Z", null, 0, 0, "09000064817631cd"], ["FDA-2014-N-0002-0032", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-327 LONGRANGE (eprinomectin) Extended Release Injectable Parasiticide Cattle on Pasture re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:06:01Z", null, 0, 0, "09000064817631ce"], ["FDA-2014-N-0002-0035", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-530 TYLOVET 100 (tylosin phosphate) plus PAYLEAN (ractopamine HCl) Type B and C medicated feeds.  re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:18:01Z", null, 0, 0, "090000648178df8c"], ["FDA-2014-N-0002-0028", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-421  DUOCARE  Ivermectin 1.87% / praziquantel 23.38% Paste Horses re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:04:52Z", null, 0, 0, "09000064817631ca"], ["FDA-2014-N-0002-0029", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-423  HALAMID Aqua Chloramine-T Powder for immersion Freshwater-reared salmonids, walleye, and freshwater-reared warmwater finfish re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:05:12Z", null, 0, 0, "09000064817631cb"], ["FDA-2014-N-0002-0033", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet Dogs re New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid; Chloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Freedom of Information Summary", "2014-07-03T04:00:00Z", 2014, 7, null, null, "2014-07-03T17:06:20Z", null, 0, 0, "09000064817631cf"], ["FDA-2014-N-0002-0025", "FDA", "FDA-2014-N-0002", "New Animal Drugs for Use in Animal Feeds; Chlortetracycline and\nSulfamethazine; Chlortetracycline; Procaine Penicillin; and\nSulfamethazine", "Rule", "Final Rule", "2014-07-02T04:00:00Z", 2014, 7, "2014-07-02T04:00:00Z", null, "2014-07-02T14:32:37Z", "2014-15274", 0, 0, "09000064817870be"], ["FDA-2014-N-0002-0026", "FDA", "FDA-2014-N-0002", "Withdrawal of Approval of Part of a New Animal Drug Application; Procaine Penicillin", "Rule", "Withdrawal", "2014-07-02T04:00:00Z", 2014, 7, "2014-07-02T04:00:00Z", null, "2015-03-23T18:12:15Z", "2014-15273", 0, 0, "0900006481786fc6"], ["FDA-2014-N-0002-0027", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Afoxalaner; Ceftiofur Crystalline Free Acid;\nChloramine-T; Clodronate; Enrofloxacin; Eprinomectin; Fluralaner; Ivermectin and Praziquantel; Niclosamide; Ractopamine; Tylosin; Change of Sponsor\u2019s Address", "Rule", "Final Rule", "2014-07-02T04:00:00Z", 2014, 7, "2014-07-02T04:00:00Z", null, "2014-07-02T15:34:44Z", "2014-15276", 0, 0, "0900006481787238"], ["FDA-2014-N-0002-0024", "FDA", "FDA-2014-N-0002", "Oral Dosage Form New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2014-05-20T04:00:00Z", 2014, 5, "2014-05-20T04:00:00Z", null, "2014-05-20T14:44:54Z", "2014-10415", 0, 0, "09000064817056d1"], ["FDA-2014-N-0002-0023", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-468 GENTAMED-P for Poultry Injection Chickens and Turkeys", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-16T04:00:00Z", 2014, 4, null, null, "2014-04-16T12:22:29Z", null, 0, 0, "09000064816b59af"], ["FDA-2014-N-0002-0022", "FDA", "FDA-2014-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-529 XYLAMED xylazine Injection", "Supporting & Related Material", "Freedom of Information Summary", "2014-04-16T04:00:00Z", 2014, 4, null, null, "2014-04-16T12:20:02Z", null, 0, 0, "09000064816b5986"], ["FDA-2014-N-0002-0021", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Ceftiofur Sodium; Gentamicin; Xylazine", "Rule", "Final Rule", "2014-04-15T04:00:00Z", 2014, 4, "2014-04-15T04:00:00Z", null, "2014-04-15T15:35:02Z", "2014-08445", 0, 0, "09000064816b3fde"], ["FDA-2014-N-0002-0019", "FDA", "FDA-2014-N-0002", "New Animal Drugs for Use in Animal Feeds; Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B;\nLincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin", "Rule", "Final Rule", "2014-04-10T04:00:00Z", 2014, 4, "2014-04-10T04:00:00Z", null, "2015-03-23T19:18:47Z", "2014-08011", 0, 0, "09000064816ad8a9"], ["FDA-2014-N-0002-0020", "FDA", "FDA-2014-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Bambermycins; Hygromycin B; Lincomycin; Pyrantel; Tylosin; Tylosin and Sulfamethazine; Virginiamycin", "Rule", "Withdrawal", "2014-04-10T04:00:00Z", 2014, 4, "2014-04-10T04:00:00Z", null, "2015-03-23T19:19:01Z", "2014-08010", 0, 0, "09000064816ad857"], ["FDA-2014-N-0002-0018", "FDA", "FDA-2014-N-0002", "Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug\nApplications for Combination Drug Medicated Feeds Containing an\nArsenical Drug; Correction", "Rule", "Withdrawal", "2014-04-07T04:00:00Z", 2014, 4, "2014-04-07T04:00:00Z", null, "2015-03-23T19:18:32Z", "2014-07702", 0, 0, "09000064816a301d"], ["FDA-2014-N-0002-0017", "FDA", "FDA-2014-N-0002", "Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug\nApplications for Combination Drug Medicated Feeds Containing an\nArsenical Drug; Correction", "Rule", "Correction", "2014-03-31T04:00:00Z", 2014, 3, "2014-03-31T04:00:00Z", null, "2014-03-31T14:56:48Z", "2014-06994", 0, 0, "0900006481691487"], ["FDA-2014-N-0002-0016", "FDA", "FDA-2014-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Change of\nSponsor", "Rule", "Final Rule", "2014-03-25T04:00:00Z", 2014, 3, "2014-03-25T04:00:00Z", null, "2014-03-25T13:46:05Z", "2014-06131", 0, 0, "090000648167c94b"], ["FDA-2014-N-0002-0015", "FDA", "FDA-2014-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Chlortetracycline; Sulfathiazole; Penicillin", "Rule", "Withdrawal", "2014-03-20T04:00:00Z", 2014, 3, "2014-03-20T04:00:00Z", null, "2015-03-23T19:18:14Z", "2014-05883", 0, 0, "0900006481671842"], ["FDA-2014-N-0002-0014", "FDA", "FDA-2014-N-0002", "Zoetis Inc., Withdrawal of Approval of New Animal Drug Applications;\nChlortetracycline; Sulfathiazole; Penicillin", "Rule", "Final Rule", "2014-03-20T04:00:00Z", 2014, 3, "2014-03-20T04:00:00Z", null, "2014-03-20T14:12:00Z", "2014-05882", 0, 0, "09000064816718df"], ["FDA-2014-N-0002-0009", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-341 SPARMECTIN-E Liquid for Horses", "Supporting & Related Material", "Freedom of Information Summary", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T14:58:46Z", null, 0, 0, "090000648166f588"], ["FDA-2014-N-0002-0010", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 140-200 EAZI-BREED CIDR Cattle Insert Progesterone intravaginal insert Anestrous Lactating Dairy Cows", "Supporting & Related Material", "Freedom of Information Summary", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T15:05:38Z", null, 0, 0, "090000648166f589"], ["FDA-2014-N-0002-0011", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-320 ONSIOR tablets Robenacoxib Cats", "Supporting & Related Material", "Freedom of Information Summary", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T15:08:48Z", null, 0, 0, "090000648166f58a"], ["FDA-2014-N-0002-0012", "FDA", "FDA-2014-N-0002", "Environmental Assessment for Use of the EAZI-BREED\u2122 CIDR\uf0d2 Cattle Insert for Induction of Estrous Cycles in Anestrous Lactating Dairy Cows", "Supporting & Related Material", "Supplement", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T15:21:58Z", null, 0, 0, "090000648166f58b"], ["FDA-2014-N-0002-0006", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-523 SULFAMED Injection 40 % Cattle", "Supporting & Related Material", "Freedom of Information Summary", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T14:53:50Z", null, 0, 0, "090000648166f03c"], ["FDA-2014-N-0002-0007", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary ANADA 200-564  Ivermectin Paste 1.87% Paste Horses", "Supporting & Related Material", "Freedom of Information Summary", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T14:46:44Z", null, 0, 0, "090000648166f586"], ["FDA-2014-N-0002-0008", "FDA", "FDA-2014-N-0002", "Freedom of Information Summary NADA 141-419 COYDEN 25 AND FLAVOMYCIN Broiler Chickens", "Supporting & Related Material", "Freedom of Information Summary", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T14:52:54Z", null, 0, 0, "090000648166f587"], ["FDA-2014-N-0002-0013", "FDA", "FDA-2014-N-0002", "Finding of No Significant Impact (FONSI) for EAZI-BREED (progesterone) CIDR Cattle Insert in Dairy Cows", "Supporting & Related Material", "Supplement", "2014-03-19T04:00:00Z", 2014, 3, null, null, "2014-03-19T15:26:01Z", null, 0, 0, "090000648166f58c"], ["FDA-2014-N-0002-0005", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2014-03-11T04:00:00Z", 2014, 3, "2014-03-11T04:00:00Z", null, "2014-03-11T14:44:15Z", "2014-04937", 0, 0, "090000648165dc9a"], ["FDA-2014-N-0002-0004", "FDA", "FDA-2014-N-0002", "Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug\nApplications for Combination Drug Medicated Feeds Containing an\nArsenical Drug", "Rule", "Withdrawal", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2015-03-23T19:17:47Z", "2014-02616", 0, 0, "09000064815d82c7"], ["FDA-2014-N-0002-0002", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Change of Sponsor", "Rule", "Final Rule", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2015-03-23T19:17:10Z", "2014-01958", 0, 0, "09000064815d85cf"], ["FDA-2014-N-0002-0001", "FDA", "FDA-2014-N-0002", "New Animal Drugs; Bambermycins; Clopidol; Ivermectin; Penicillin G\nProcaine and Dihydrostreptomycin Sulfate; Progesterone; Robenicoxib;\nSulfadimethoxine; Change of Sponsor; Change of Sponsor\u2019s Address", "Rule", "Final Rule", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2015-03-23T19:16:55Z", "2014-01959", 0, 0, "09000064815d861b"], ["FDA-2014-N-0002-0003", "FDA", "FDA-2014-N-0002", "Zoetis Inc., et al.; Withdrawal of Approval of New Animal Drug\nApplications for Combination Drug Medicated Feeds Containing an\nArsenical Drug", "Rule", "Final Rule", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2015-03-23T19:17:31Z", "2014-02617", 0, 0, "09000064815d82c8"]], "truncated": false, "filtered_table_rows_count": 85, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2014-N-0002"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002", "results": [{"value": "FDA", "label": "FDA", "count": 85, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2014-N-0002", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 61, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002", "results": [{"value": 2014, "label": 2014, "count": 66, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&posted_year=2014", "selected": false}, {"value": 2015, "label": 2015, "count": 18, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&posted_year=2015", "selected": false}, {"value": 2016, "label": 2016, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&posted_year=2016", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-0002&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1820.302746957168, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}